Maryland Gov. Hogan announces Korean firm UNDBIO to establish R&D lab in Rockville

Maryland Gov. Larry Hogan meeting with
South Korean President Yoon Suk-yeol in Seoul 

Maryland Gov. Larry Hogan (R) announced more positive economic developments for his state from his economic development trip to Asia today. Rockville is one of the winners in Hogan's outreach, as the governor reported that South Korean biotech firm UNDBIO has agreed to establish a 25,000 square foot research and development facility here. Twinlabs, a Rockville real estate firm that specializes in life sciences, reached a lease agreement with UNDBIO, who have committed $100,000,000 to the project.

UNDBIO anticipates the new facility will develop and manufacture insulin samples for FDA approval. These approved products will then enter the pharmaceutical market. The company possesses unique proprietary insulin production technology, which will be employed in the Rockville venture.

"Maryland is proud to be home to hundreds of life sciences companies that set the bar for biotechnology innovation and fuel our region’s innovative economy, and we are excited to welcome the life-saving work of UNDBIO to Rockville,” Hogan said in a statement this afternoon. “This is yet another shining example that Maryland is open for business and further evidence of our state’s special bond with the Republic of Korea.”

“I am happy to establish our relationship with the State of Maryland to undertake the research and development required to produce affordable insulin and insulin analogues for the diabetic population around the globe,” UNDBIO’s Chairman Jun Yong-soo said. “We look forward to developing high paying biotech jobs for Maryland, and would welcome other partners into our global insulin project.”